192 related articles for article (PubMed ID: 27014565)
1. Ascorbic acid serum levels are reduced in patients with hematological malignancies.
Huijskens MJ; Wodzig WK; Walczak M; Germeraad WT; Bos GM
Results Immunol; 2016; 6():8-10. PubMed ID: 27014565
[TBL] [Abstract][Full Text] [Related]
2. The Role of Complement Activating Collectins and Associated Serine Proteases in Patients With Hematological Malignancies, Receiving High-Dose Chemotherapy, and Autologous Hematopoietic Stem Cell Transplantations (Auto-HSCT).
Świerzko AS; Michalski M; Sokołowska A; Nowicki M; Eppa Ł; Szala-Poździej A; Mitrus I; Szmigielska-Kapłon A; Sobczyk-Kruszelnicka M; Michalak K; Gołos A; Wierzbowska A; Giebel S; Jamroziak K; Kowalski ML; Brzezińska O; Thiel S; Jensenius JC; Kasperkiewicz K; Cedzyński M
Front Immunol; 2018; 9():2153. PubMed ID: 30294330
[TBL] [Abstract][Full Text] [Related]
3. Thymopoiesis in Pre- and Post-Hematopoietic Stem Cell Transplantation.
da Rocha LKA; Freschi de Barros S; Bandeira F; Bollini A; Testa LHA; Simione AJ; Souza MOE; Zanetti LP; de Oliveira LCS; Dos Santos ACF; de Souza MP; Colturado VAR; Kalil J; Machado CM; Guilherme L
Front Immunol; 2018; 9():1889. PubMed ID: 30245685
[TBL] [Abstract][Full Text] [Related]
4. Influence of Vitamin C on Lymphocytes: An Overview.
van Gorkom GNY; Klein Wolterink RGJ; Van Elssen CHMJ; Wieten L; Germeraad WTV; Bos GMJ
Antioxidants (Basel); 2018 Mar; 7(3):. PubMed ID: 29534432
[TBL] [Abstract][Full Text] [Related]
5. [Early immune reconstitution after hematopoietic stem cell transplantation].
Zhu MX; Wan WL; Li HS; Wang J; Wang YF; Hu K; Ke XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Jun; 48(3):515-22. PubMed ID: 27318917
[TBL] [Abstract][Full Text] [Related]
6. Perioperative management after high-dose chemotherapy with autologous or allogeneic hematopoietic stem cell transplantation for pediatric solid tumors.
Uehara S; Oue T; Nakahata K; Nara K; Ueno T; Owari M; Usui N; Miyamura T; Hashii Y
Eur J Pediatr Surg; 2015 Feb; 25(1):118-22. PubMed ID: 25111275
[TBL] [Abstract][Full Text] [Related]
7. Technical advance: ascorbic acid induces development of double-positive T cells from human hematopoietic stem cells in the absence of stromal cells.
Huijskens MJ; Walczak M; Koller N; Briedé JJ; Senden-Gijsbers BL; Schnijderberg MC; Bos GM; Germeraad WT
J Leukoc Biol; 2014 Dec; 96(6):1165-75. PubMed ID: 25157026
[TBL] [Abstract][Full Text] [Related]
8. [Hematopoietic stem cell transplantation for hematological malignancies].
Zhong MZ; Chen FP; Shu YG
Hunan Yi Ke Da Xue Xue Bao; 2002 Jun; 27(3):242-4. PubMed ID: 12575304
[TBL] [Abstract][Full Text] [Related]
9. Ascorbic acid promotes proliferation of natural killer cell populations in culture systems applicable for natural killer cell therapy.
Huijskens MJ; Walczak M; Sarkar S; Atrafi F; Senden-Gijsbers BL; Tilanus MG; Bos GM; Wieten L; Germeraad WT
Cytotherapy; 2015 May; 17(5):613-20. PubMed ID: 25747742
[TBL] [Abstract][Full Text] [Related]
10. [A comparative study of induction chemotherapy with or without autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed young medium/high risk diffuse large B cell lymphoma patients].
Wang X; Xia B; Wang CY; Li MZ; Xu W; Yuan T; Tian C; Zhao HF; Yang HL; Zhao ZG; Wang XF; Wang YF; Yu Y; Zhang YZ
Zhonghua Xue Ye Xue Za Zhi; 2019 Feb; 40(2):117-124. PubMed ID: 30831626
[No Abstract] [Full Text] [Related]
11. Immune Reconstitution of CD4+T Cells after Allogeneic Hematopoietic Stem Cell Transplantation and its Correlation with Invasive Fungal Infection in Patients with Hematological Malignancies.
Peng XG; Dong Y; Zhang TT; Wang K; Ma YJ
Asian Pac J Cancer Prev; 2015; 16(8):3137-40. PubMed ID: 25921110
[TBL] [Abstract][Full Text] [Related]
12. Ascorbic acid, but not dehydroascorbic acid increases intracellular vitamin C content to decrease Hypoxia Inducible Factor -1 alpha activity and reduce malignant potential in human melanoma.
Fischer AP; Miles SL
Biomed Pharmacother; 2017 Feb; 86():502-513. PubMed ID: 28012930
[TBL] [Abstract][Full Text] [Related]
13. Review of "minitransplantation": nonmyeloablative allogeneic hematopoietic stem cell transplantation.
Georges GE; Storb R
Int J Hematol; 2003 Jan; 77(1):3-14. PubMed ID: 12568294
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin G Fragment Crystallizable Glycosylation After Hematopoietic Stem Cell Transplantation Is Dissimilar to Donor Profiles.
de Haan N; van Tol MJD; Driessen GJ; Wuhrer M; Lankester AC
Front Immunol; 2018; 9():1238. PubMed ID: 29915589
[TBL] [Abstract][Full Text] [Related]
15. Endothelial Function in Patients with Hematologic Malignancies Undergoing High-Dose Chemotherapy Followed by Hematopoietic Stem Cell Transplantation.
Poręba M; Gać P; Usnarska-Zubkiewicz L; Pilecki W; Kuliczkowski K; Mazur G; Sobieszczańska M; Poręba R
Cardiovasc Toxicol; 2016 Apr; 16(2):156-62. PubMed ID: 25855515
[TBL] [Abstract][Full Text] [Related]
16. NK Cell Functional Impairment after Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Reduced Levels of T-bet and Eomesodermin.
Simonetta F; Pradier A; Bosshard C; Masouridi-Levrat S; Chalandon Y; Roosnek E
J Immunol; 2015 Nov; 195(10):4712-20. PubMed ID: 26438526
[TBL] [Abstract][Full Text] [Related]
17. Anti-Aspergillus immunoglobulin-G testing in serum of hematopoietic stem cell transplant recipients.
Erdmann JH; Graf B; Blau IW; Fischer F; Timm G; Hemmati P; Arnold R; Penack O
Transpl Infect Dis; 2016 Jun; 18(3):354-60. PubMed ID: 26998687
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies.
Liu J; Zhong JF; Zhang X; Zhang C
J Hematol Oncol; 2017 Jan; 10(1):35. PubMed ID: 28143567
[TBL] [Abstract][Full Text] [Related]
19. Reconstitution of lymphocyte subpopulations after hematopoietic stem cell transplantation: comparison of hematologic malignancies and donor types in event-free patients.
Park BG; Park CJ; Jang S; Chi HS; Kim DY; Lee JH; Lee JH; Lee KH
Leuk Res; 2015 Dec; 39(12):1334-41. PubMed ID: 26422556
[TBL] [Abstract][Full Text] [Related]
20. Graft Engineering and Adoptive Immunotherapy: New Approaches to Promote Immune Tolerance After Hematopoietic Stem Cell Transplantation.
Bertaina A; Roncarolo MG
Front Immunol; 2019; 10():1342. PubMed ID: 31354695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
